<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten cases were treated with systematic administration of <z:chebi fb="1" ids="29864">mannitol</z:chebi> followed by the <z:chebi fb="3" ids="38849">blood substitute</z:chebi>, perfluorochemicals, in the <z:hpo ids='HP_0011009'>acute</z:hpo> period of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in order to suppress the development of infarction and progressive deterioration </plain></SENT>
<SENT sid="1" pm="."><plain>This chemotherapy was followed by reconstructive vascular surgery </plain></SENT>
<SENT sid="2" pm="."><plain>There were 8 cases of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and 2 other cases in which cerebral <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> occurred during surgery </plain></SENT>
<SENT sid="3" pm="."><plain>Due to this treatment, there were no cases of aggravated condition or <z:hpo ids='HP_0011420'>death</z:hpo> and at the time of follow-up examination after 2 months, and 8 of the ten patients returned to productive lives </plain></SENT>
<SENT sid="4" pm="."><plain>We consequently believe that this therapeutic method may prove to be the effective means for treating <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in the <z:hpo ids='HP_0011009'>acute</z:hpo> period </plain></SENT>
<SENT sid="5" pm="."><plain>It is also thought that this method is applicable in surgical cases where long-term <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> is required </plain></SENT>
</text></document>